Skip to main content
S 935 118th Congress Senate Health

Fair Accountability and Innovative Research Drug Pricing Act of 2023

Introduced: March 22, 2023 Introduced by: Baldwin, Tammy Democratic · Wisconsin See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 22, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 22, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Fair Accountability and Innovative Research Drug Pricing Act of 2023

This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month.

Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug. Manufacturers are subject to civil penalties for failing to comply with the bill's requirements. Additionally, the Food and Drug Administration must post the information on its website.

What's happening now March 22, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 2
D
Heinrich, Martin
New Mexico · Apr 30, 2024
 D
Smith, Tina
Minnesota · Mar 22, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). S. 935: Fair Accountability and Innovative Research Drug Pricing Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-S-935/
MLA
"S. 935: Fair Accountability and Innovative Research Drug Pricing Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-935/.
Bluebook (legal)
S. 935, 118th Cong. (2026), https://openamerica.io/bill/118-S-935/.
Markdown link
[S. 935: Fair Accountability and Innovative Research Drug Pricing Act of 2023](https://openamerica.io/bill/118-S-935/)
Report a problem